Feng Zong Selected Research

KATP Channels

11/2011

Iptakalim, a novel ATP-sensitive potassium channel opener, inhibits pulmonary arterial smooth muscle cell proliferation by downregulation of PKC-α.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Feng Zong Research Topics

Disease

2	Neoplasms (Cancer) 01/2013 - 01/2012
2	Pulmonary Hypertension 06/2012 - 11/2011
2	Hypoxia (Hypoxemia) 03/2012 - 11/2011
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019
1	Fungal Lung Diseases 08/2016
1	Mycoses (Diseases, Fungus) 07/2014
1	Lung Neoplasms (Lung Cancer) 01/2013
1	Familial Primary Pulmonary Hypertension 06/2012
1	Prostatic Neoplasms (Prostate Cancer) 01/2012
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2012
1	Vascular Remodeling 11/2011

Drug/Important Bio-Agent (IBA)

2	Adenosine Triphosphate (ATP)IBA 03/2012 - 11/2011
2	N- (1- methylethyl)- 1,1,2- trimethylpropylamineIBA 03/2012 - 11/2011
1	MicroRNAs (MicroRNA)IBA 01/2019
1	Serum AlbuminIBA 08/2016
1	2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA 01/2013
1	Cisplatin (Platino)FDA LinkGeneric 01/2013
1	Small Interfering RNA (siRNA)IBA 01/2013
1	Adenosine (Adenocard)FDA LinkGeneric 06/2012
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 06/2012
1	Vasodilator Agents (Vasodilators)IBA 06/2012
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2012
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 03/2012
1	Conditioned Culture MediaIBA 03/2012
1	Caspase 9IBA 01/2012
1	CaspasesIBA 01/2012
1	PotassiumIBA 11/2011
1	KATP ChannelsIBA 11/2011

Therapy/Procedure

1	Transplantation 07/2014
1	Drug Therapy (Chemotherapy) 01/2013